Literature DB >> 28696707

Cyclophilin B Deficiency Causes Abnormal Dentin Collagen Matrix.

Masahiko Terajima1, Yuki Taga2, Wayne A Cabral3, Masako Nagasawa4, Noriko Sumida1, Shunji Hattori2, Joan C Marini3, Mitsuo Yamauchi1.   

Abstract

Cyclophilin B (CypB) is an endoplasmic reticulum-resident protein that regulates collagen folding, and also contributes to prolyl 3-hydroxylation (P3H) and lysine (Lys) hydroxylation of collagen. In this study, we characterized dentin type I collagen in CypB null (KO) mice, a model of recessive osteogenesis imperfecta type IX, and compared to those of wild-type (WT) and heterozygous (Het) mice. Mass spectrometric analysis demonstrated that the extent of P3H in KO collagen was significantly diminished compared to WT/Het. Lys hydroxylation in KO was significantly diminished at the helical cross-linking sites, α1/α2(I) Lys-87 and α1(I) Lys-930, leading to a significant increase in the under-hydroxylated cross-links and a decrease in fully hydroxylated cross-links. The extent of glycosylation of hydroxylysine residues was, except α1(I) Lys-87, generally higher in KO than WT/Het. Some of these molecular phenotypes were distinct from other KO tissues reported previously, indicating the dentin-specific control mechanism through CypB. Histological analysis revealed that the width of predentin was greater and irregular, and collagen fibrils were sparse and significantly smaller in KO than WT/Het. These results indicate a critical role of CypB in dentin matrix formation, suggesting a possible association between recessive osteogenesis imperfecta and dentin defects that have not been clinically detected.

Entities:  

Keywords:  collagen; cyclophilin B; dentin; glycosylation; hydroxylysine; post-translational modification

Mesh:

Substances:

Year:  2017        PMID: 28696707     DOI: 10.1021/acs.jproteome.7b00190

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

1.  Dental and craniofacial defects in the Crtap-/- mouse model of osteogenesis imperfecta type VII.

Authors:  He Xu; Sydney A Lenhart; Emily Y Chu; Michael B Chavez; Helen F Wimer; Milena Dimori; Martha J Somerman; Roy Morello; Brian L Foster; Nan E Hatch
Journal:  Dev Dyn       Date:  2020-03-12       Impact factor: 3.780

2.  Cyclophilin B control of lysine post-translational modifications of skin type I collagen.

Authors:  Masahiko Terajima; Yuki Taga; Wayne A Cabral; Ying Liu; Masako Nagasawa; Noriko Sumida; Yukako Kayashima; Prashant Chandrasekaran; Lin Han; Nobuyo Maeda; Irina Perdivara; Shunji Hattori; Joan C Marini; Mitsuo Yamauchi
Journal:  PLoS Genet       Date:  2019-06-07       Impact factor: 5.917

3.  Type III collagen is a key regulator of the collagen fibrillar structure and biomechanics of articular cartilage and meniscus.

Authors:  Chao Wang; Becky K Brisson; Masahiko Terajima; Qing Li; Kevt'her Hoxha; Biao Han; Abby M Goldberg; X Sherry Liu; Michele S Marcolongo; Motomi Enomoto-Iwamoto; Mitsuo Yamauchi; Susan W Volk; Lin Han
Journal:  Matrix Biol       Date:  2019-10-23       Impact factor: 11.583

4.  The Role of Endoplasmic Reticulum Chaperones in Protein Folding and Quality Control.

Authors:  Benjamin M Adams; Nathan P Canniff; Kevin P Guay; Daniel N Hebert
Journal:  Prog Mol Subcell Biol       Date:  2021

5.  Collagen molecular phenotypic switch between non-neoplastic and neoplastic canine mammary tissues.

Authors:  Masahiko Terajima; Yuki Taga; Becky K Brisson; Amy C Durham; Kotaro Sato; Katsuhiro Uzawa; Tomoaki Saito; Shunji Hattori; Karin U Sørenmo; Mitsuo Yamauchi; Susan W Volk
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.996

6.  Lysyl hydroxylase 2 mediated collagen post-translational modifications and functional outcomes.

Authors:  Masahiko Terajima; Yuki Taga; Tomoyuki Nakamura; Hou-Fu Guo; Yukako Kayashima; Nobuyo Maeda-Smithies; Kshitij Parag-Sharma; Jeong Seon Kim; Antonio L Amelio; Kazunori Mizuno; Jonathan M Kurie; Mitsuo Yamauchi
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.